Tag: Underwritten Public Offering

June 17, 2018

5 Top Weekly NASDAQ Tech Stocks: AGM Holdings Up 175 Percent

Which NASDAQ tech stocks gained the most last week? AGM Holdings, Nano Dimension, CLPS, Net Element and Foresight Autonomous Holdings...
June 3, 2018

5 Top Weekly NASDAQ Tech Stocks: Index Steers Ahead

Which NASDAQ tech stocks gained the most last week? Netlist, ACMR Research, The Meet Group, Quicklogic and MySize Inc took...
May 8, 2018

AxoGen Announces Proposed Public Offering of Common Stock

AxoGen (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced today that it has...
April 29, 2018

5 Top Weekly NASDAQ Tech Stocks: Index Dip Continues

SemiLEDs, AGM Group Holdings, Brightcove, Kingtone Wirelessinfo Solution Holding and Foresight Autonomous Holdings were the top gainers last week.
April 27, 2018

Onconova Therapeutics Announces Pricing of $25.0 Million Upsized Underwritten Public Offering

Onconova Therapeutics (NASDAQ:ONTX) a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat...
April 26, 2018

Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock

Eloxx Pharmaceuticals (Nasdaq:ELOX) today announced the pricing of an underwritten public offering of 5,130,000 shares of its common stock at...
April 25, 2018

Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock

Eloxx Pharmaceuticals (OTCQB:ELOX) today announced that it intends to offer and sell, subject to market and other conditions, 5,000,000 shares...
April 22, 2018

5 Top Weekly NASDAQ Tech Stocks: Index Dip Continues

Which NASDAQ tech stocks gained the most last week? Mattersight, RealNetworks, Meet Group, Iteris and Computer Task Group were the...
April 19, 2018

Aeglea BioTherapeutics Prices Public Offering of Common Stock

Aeglea BioTherapeutics (Nasdaq:AGLE) a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic...
April 19, 2018

Apellis Pharmaceuticals Announces Pricing of Offering of Common Stock

Apellis Pharmaceuticals (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the...